Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FAISAL N MASUD

Allopathic & Osteopathic Physicians Anesthesiology Critical Care Medicine

NPI
1023054525
CMS profile
699
Location
HOUSTON, TX

General Payments · PY2018–2024

$157,234.61

  • Reported across 189 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$38,985.39

44 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $23,929.28 26
Teleflex LLC $8,907.56 7
Acerta Pharma LLC $5,997.68 7
BOSTON SCIENTIFIC CORPORATION $150.87 4

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $16,684.48 30
PY2019 $6,916.85 16
PY2020 $4,750.00 3
PY2021 $22,278.74 19
PY2022 $22,257.80 21
PY2023 $45,361.35 56
PY2024 $38,985.39 44

Payment records · PY2024 (44)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $119.74 03/27/2024 Food and Beverage Undisputed 01/23/2026 1104568802 CMS
AstraZeneca Pharmaceuticals LP $69.26 03/27/2024 Travel and Lodging Undisputed 01/23/2026 1105871769 CMS
AstraZeneca Pharmaceuticals LP $3,200.00 03/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105292117 CMS
AstraZeneca Pharmaceuticals LP $300.00 06/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105805438 CMS
AstraZeneca Pharmaceuticals LP $36.82 09/26/2024 Travel and Lodging Undisputed 01/23/2026 1104496668 CMS
AstraZeneca Pharmaceuticals LP $121.86 09/26/2024 Food and Beverage Undisputed 01/23/2026 1104625664 CMS
AstraZeneca Pharmaceuticals LP $2,150.00 10/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104244409 CMS
Boston Scientific Corporation $12.01 07/30/2024 Food and Beverage Undisputed 01/23/2026 1092618984 CMS
Boston Scientific Corporation $102.28 08/22/2024 Food and Beverage Undisputed 01/23/2026 1092618990 CMS
Boston Scientific Corporation $22.86 08/28/2024 Food and Beverage Undisputed 01/23/2026 1092618988 CMS
Boston Scientific Corporation $13.72 08/29/2024 Food and Beverage Undisputed 01/23/2026 1092618986 CMS
Gilead Sciences, Inc. $4,500.00 02/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133603286 CMS
Gilead Sciences, Inc. $48.04 03/09/2024 Food and Beverage Undisputed 01/23/2026 1133736862 CMS
Gilead Sciences, Inc. $48.19 03/09/2024 Food and Beverage Undisputed 01/23/2026 1133736864 CMS
Gilead Sciences, Inc. $383.07 03/09/2024 Travel and Lodging Undisputed 01/23/2026 1133861700 CMS
Gilead Sciences, Inc. $719.21 03/09/2024 Travel and Lodging Undisputed 01/23/2026 1133861702 CMS
Gilead Sciences, Inc. $27.66 04/05/2024 Food and Beverage Undisputed 01/23/2026 1133736866 CMS
Gilead Sciences, Inc. $211.71 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1133861704 CMS
Gilead Sciences, Inc. $337.93 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1133861706 CMS
Gilead Sciences, Inc. $530.60 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1133861708 CMS
Gilead Sciences, Inc. $102.60 09/25/2024 Food and Beverage Undisputed 01/23/2026 1133736868 CMS
Gilead Sciences, Inc. $17.58 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1133861710 CMS
Gilead Sciences, Inc. $2,470.00 10/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133603288 CMS
Gilead Sciences, Inc. $85.25 10/01/2024 Food and Beverage Undisputed 01/23/2026 1133736870 CMS
Gilead Sciences, Inc. $198.96 10/01/2024 Travel and Lodging Undisputed 01/23/2026 1133861712 CMS
Gilead Sciences, Inc. $499.54 10/01/2024 Travel and Lodging Undisputed 01/23/2026 1133861714 CMS
Gilead Sciences, Inc. $534.95 10/01/2024 Travel and Lodging Undisputed 01/23/2026 1133861716 CMS
Gilead Sciences, Inc. $9.87 10/03/2024 Food and Beverage Undisputed 01/23/2026 1133736872 CMS
Gilead Sciences, Inc. $41.04 10/03/2024 Food and Beverage Undisputed 01/23/2026 1133736874 CMS
Gilead Sciences, Inc. $96.22 10/03/2024 Travel and Lodging Undisputed 01/23/2026 1133861718 CMS
Gilead Sciences, Inc. $4,190.00 10/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133603290 CMS
Gilead Sciences, Inc. $117.79 11/14/2024 Food and Beverage Undisputed 01/23/2026 1133736876 CMS
Gilead Sciences, Inc. $614.07 11/14/2024 Travel and Lodging Undisputed 01/23/2026 1133861720 CMS
Gilead Sciences, Inc. $2,470.00 11/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133603292 CMS
Gilead Sciences, Inc. $735.00 11/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133603294 CMS
Gilead Sciences, Inc. $2,470.00 12/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133603296 CMS
Gilead Sciences, Inc. $2,470.00 12/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1133603298 CMS
Teleflex LLC $8,000.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1142068099 CMS
Teleflex LLC $355.58 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1142072298 CMS
Teleflex LLC $60.00 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1142072300 CMS
Teleflex LLC $58.33 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1142080716 CMS
Teleflex LLC $46.90 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1142080718 CMS
Teleflex LLC $289.75 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1142084906 CMS
Teleflex LLC $97.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 1142084904 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.